ArticleJournal of neuro-oncology2018

Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.

Aikaterini Kotrotsou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.